Medical News Today -
24 Feb 2014 12:00
The Global CEO Initiative (CEOi) on Alzheimer's Disease and the New York Academy of Sciences (the Academy) today (February 20th) convened representatives from industry, academia, government and nonprofits to launch the development of a Global Alzheimer's Platform (GAP), designed to reduce the time and costs of Alzheimer's clinical trials, develop an infrastructure that promotes innovation, and assure international collaboration."Alzheimer's is a global epidemic that must be addressed with urgenc...
Share this Article